Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia: A metaphase-FISH study

British Journal of Haematology

Volumn 92, Issue 2, 1996, Pages 365-369

  El Rifai, Wa'el ^a,b   Ruutu, Tapani ^a   Vettenranta, Kim ^a   Temtamy, Samia ^b   Knuutila, Sakari ^a,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL RESEARCH CENTRE   (Egypt)

^c Central Hospital ^*  (Finland)

Author keywords

Chronic myeloid leukaemia; Minimal residual disease; Nuorescence in situ hybridization

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; FEMALE; HUMAN; IN SITU HYBRIDIZATION; LEUKEMIA CELL; MALE; METAPHASE; PRIORITY JOURNAL; SOUTHERN BLOTTING;

EID: 0030026450     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1507.x     Document Type: Article

References (25)

1. Bar, B.M., Schattenberg, A., Mensink, E.J., Geurts Van Kessel, A., Smetsers, T.F., Knops, G.H., Linders, E.H. & De Witte, T. (1993) Donor leukocyte transfusions for chronic myelogenous leukemia after allogeneic bone marrow transplantation. Journal of Clinical Oncolology, 11, 513-519.
2. Bentz, M., Hartmut, D., Georges, C. & Lichter, P. (1994) Fluorescence in situ hybridization in leukemias: 'the FISH are spawning!'. Leukemia, 8, 1447-1452.
3. Champlin, R. & Golde, D. (1985) Chronic myelogenous leukemia: recent advances. Blood, 65, 1039-1047.
4. Cremer, T., Lichter, P., Borden, J., Ward, D.C. & Manuelidis, L. (1988) Detection of chromosome aberrations in metaphase and interphase tumor cells by in situ hybridization using chromosome-specific library probes. Human Genetics, 80, 235-246.
5. Cross, N.C.P., Feng, L., Chase, A., Bungey, J., Hughes, T.P. & Goldman, J.M. (1993a) Competitive polymerase chain reaction to estimate the number of bcr-abl transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood, 82, 1929-1936.
6. Cross, N.C.P., Hughes, T.P., Feng, L., O'Shea, P., Bungey, J., Marks, D., Ferrant, A., Martiat, P. & Goldman, J. (1993b) Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlation with acute graft-versus-host diseases and relapse. British Journal of Haematolology, 84, 67-74.
7. Delage, R., Titz, J. & Anderson, K.C. (1990) The evolving role of bone marrow transplantation in the treatment of chronic myelogenous leukemia. Hematology/Oncology Clinics of North America, 4, 369-388.
8. Drobyski, W.R., Keever, C.A., Roth, M.S., Koethe, S., Hanson, G., McFadden, P., Gottschall, J.L., Ash, R.C., Van Tuinen, P., Horowitz, M.M. & Flomenberg, N. (1993) Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose. Blood, 82, 2310-2318.
9. Frenoy, N., Chabli, A., Sol, O., Goldschmit, E., Lemonnier, M.P., Misset, J.L. & Debuire, B. (1994) Application of a new nested PCR to the detection of minimal residual disease bcr/abl transcripts. Leukemia, 8, 1411-1414.
10. Giralt, S. & Champlin, R. (1994) Leukemia relapse after allogeneic bone marrow transplantation: a review. Blood, 84, 3603-3612.
11. Hertenstein, B., Wiesneth, M., Novotny, J., Bunjes, D., Stefanic, M., Heinze, B., Hubner, G., Heimpel, H. & Arnold, R. (1993) Interferon-α and donor buffy coat transfusions for treatment of relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation. Transplantation, 56, 1114-1118.
12. ISCN (1991) Guidelines for Cancer Cytogenetics: Supplement to an International System for Human Cytogenetic Nomenclature (ed. by F. Mitelman). S. Karger, Basel.
13. Kantarjian, H., Deisseroth, A., Kurzrock, R., Estrov, Z. & Taplaz, M. (1993) Chronic myelogenous leukemia: a concise update. Blood, 82, 691-703.
14. Kibbelaar, R.E., Mulder, J.W.R., Dreef, E.J., van Kamp, H., Fibbe, W.E., Wessels, J.W., Beverstock, G.C. Haak, H.L. & Kluin, P. (1993) Detection of monosomy 7 and trisomy 8 in myeloid neoplasia: a comparison of banding and fluorescence in situ hybridization. Blood, 82, 904-913.
15. Kolb, H., Mittermuller, J., Clemm, C., Holler, E., Ledrerose, G., Brehm, G., Heim, M. & Wilmanns, W. (1990) Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood, 76, 2462-2465.
16. Lion, T., Henn, T., Gaiger, A., Kalhs, P. & Gander, H. (1993) Early detection of relapse after bone marrow transplantation in patients with chronic myelogenous leukaemia. Lancet, 341, 275-276.
17. Miyamura, K., Barrett, A.J., Kodera, Y. & Saito, H. (1994) Minimal residual disease after bone marrow transplantation for chronic myelogenous leukemia and implication for graft-versus-leukemia effect: a review of recent results. Bone Marrow Transplantation, 14, 201-209.
18. Nylund, S., Ruutu, T., Saarinen, U. & Knuutila, S. (1994a) Metaphase fluorescence in situ hybridization (FISH) in the follow-up of 60 patients with haemopoietic malignancies. British Journal of Haematolology, 88, 778-783.
19. Nylund, S., Ruutu, T., Saarinen, U., Larramendy, M. & Knuutila, S. (1994b) Detection of minimal residual disease using fluorescence DNA in situ hybridization: a follow-up study in leukemia and lymphoma patients. Leukemia, 8, 587-594.
20. Pinkel, D., Straume, T. & Gray, J.W. (1986) Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proceedings of National Academy of Science of the United States of America, 83, 2954-2938.
21. Slavin, S., Weiss, L., Ackerstein, A., Vourka-Karussis, U., Morecki, S., Or, R., Nagler, A., Kapelushnik, J., Delukina, M., Darkos, P. & Naparstek, E. (1993) Prevention and treatment of relapse by bone marrow transplantation. Bone Marrow Transplantation, 12, S54-S56.
22. Thomas, E.D., Clift, R.A., Feffer, A.A., Appelbaum, F., Beatty, P., Bensinger, W., Buckner, C., Cheever, M., Deeg, H., Doney, K., Flournoy, N., Greenberg, P., Hansen, J., Martin, P., McGuffin, R., Ramberg, R., Sanders, J., Singer, J., Stewart, P., Storb, R., Sullivan, K., Weiden, P. & Witherspoon, R. (1986) Marrow transplantation for the treatment of chronic myelogenous leukemia. Annals of Internal Medicine, 104, 155-163.
23. van Rhee, F., Lin, F., Cullis, J., Spencer, A., Cross, N., Chase, A., Garicochea, B., Bungey, J., Barrett, J. & Goldman, J. (1994) Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse. Blood, 83, 3377.
24. Xu, M.W., Piao, X.H., Addy, L., Jamal, N., Minden, M.D. & Messner, H.A. (1994) Minimal residual disease in bone marrow transplant recipients with chronic myeloid leukemia. Bone Marrow Transplantation, 14, 299-306.
25. Zhao, L., Kantarijan, H., Van Oort, J., Cork, A., Trujillo, J. & Liang, J. (1993) Detection of residual proliferating leukemic cells by fluorescence in situ hybridization in CML patients in completeremission after interferon treatment. Leukemia, 7, 168-171.